U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C22H31N3O3
Molecular Weight 385.4998
Optical Activity ( + / - )
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Taziprinone

SMILES

CN1CCN(CCC(=O)N[C@@H]2[C@@H]3OC4=CC=C(C)C=C4[C@]3(C)CCC2=O)CC1

InChI

InChIKey=IQRFTIWMGLZYTL-FKBYEOEOSA-N
InChI=1S/C22H31N3O3/c1-15-4-5-18-16(14-15)22(2)8-6-17(26)20(21(22)28-18)23-19(27)7-9-25-12-10-24(3)11-13-25/h4-5,14,20-21H,6-13H2,1-3H3,(H,23,27)/t20-,21-,22-/m0/s1

HIDE SMILES / InChI

Molecular Formula C22H31N3O3
Molecular Weight 385.4998
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Substance Class Chemical
Created
by admin
on Wed Apr 02 09:08:44 GMT 2025
Edited
by admin
on Wed Apr 02 09:08:44 GMT 2025
Record UNII
MVC7EI41TU
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
taziprinone [INN]
Preferred Name English
Taziprinone
INN  
INN  
Official Name English
rel-N-[(4R,4aR,9bS)-1,2,3,4,4a,9b-Hexahydro-8,9b-dimethyl-3-oxo-4-dibenzofuranyl]-4-methyl-1-piperazinepropanamide
Systematic Name English
1-Piperazinepropanamide, N-(1,2,3,4,4a,9b-hexahydro-8,9b-dimethyl-3-oxo-4-dibenzofuranyl)-4-methyl-, (4?,4a?,9b?)-(±)-
Systematic Name English
1-Piperazinepropanamide, N-[(4R,4aR,9bS)-1,2,3,4,4a,9b-hexahydro-8,9b-dimethyl-3-oxo-4-dibenzofuranyl]-4-methyl-, rel-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C66917
Created by admin on Wed Apr 02 09:08:44 GMT 2025 , Edited by admin on Wed Apr 02 09:08:44 GMT 2025
Code System Code Type Description
CAS
79253-92-2
Created by admin on Wed Apr 02 09:08:44 GMT 2025 , Edited by admin on Wed Apr 02 09:08:44 GMT 2025
PRIMARY
NCI_THESAURUS
C76478
Created by admin on Wed Apr 02 09:08:44 GMT 2025 , Edited by admin on Wed Apr 02 09:08:44 GMT 2025
PRIMARY
EPA CompTox
DTXSID501024632
Created by admin on Wed Apr 02 09:08:44 GMT 2025 , Edited by admin on Wed Apr 02 09:08:44 GMT 2025
PRIMARY
INN
5149
Created by admin on Wed Apr 02 09:08:44 GMT 2025 , Edited by admin on Wed Apr 02 09:08:44 GMT 2025
PRIMARY
FDA UNII
MVC7EI41TU
Created by admin on Wed Apr 02 09:08:44 GMT 2025 , Edited by admin on Wed Apr 02 09:08:44 GMT 2025
PRIMARY
EVMPD
SUB10848MIG
Created by admin on Wed Apr 02 09:08:44 GMT 2025 , Edited by admin on Wed Apr 02 09:08:44 GMT 2025
PRIMARY
ChEMBL
CHEMBL2218864
Created by admin on Wed Apr 02 09:08:44 GMT 2025 , Edited by admin on Wed Apr 02 09:08:44 GMT 2025
PRIMARY
SMS_ID
100000082433
Created by admin on Wed Apr 02 09:08:44 GMT 2025 , Edited by admin on Wed Apr 02 09:08:44 GMT 2025
PRIMARY
PUBCHEM
173619
Created by admin on Wed Apr 02 09:08:44 GMT 2025 , Edited by admin on Wed Apr 02 09:08:44 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY
Antitussive drug that has a different mechanism of action from those of previous and existing antitussive drugs.